Morepen Labs starts ₹825 crore CDMO contract supply
after close1 source ↓written by the desknot a recommendation
- has commenced
- ₹825 crore CDMO contract
- in Q1 FY2026-27
- ₹50 crore shipment
- in Q2
- 50% revenue surge
- in additional supplies
- ₹225 crore
- expansion plan targeting
- 1,000 KL
Morepen Labs has commenced its ₹825 crore CDMO contract, completing a ₹50 crore shipment in Q1 FY2026-27. The company anticipates a 50% revenue surge in Q2, supported by ₹225 crore in additional supplies and a significant capacity expansion plan targeting 1,000 KL. This operational milestone enhances its position in the pharmaceutical manufacturing sector.
Not investment advice. For informational purposes only.